Subject Index Vol. 23, 2006
Neerav Goyal, Hidejiro Kawahara, Dirk T. Ubbink(Amsterdam University Medical Centers), Li Yo, Beat P. Müller‐Stich(Center for Digestive and Liver Diseases), N. V. Emel'Yanov(Centre National de la Recherche Scientifique), Koroush S. Haghighi, Jürgen Weitz(University Hospital Carl Gustav Carus), Ivo Giovannini, Esther C. J. Consten(University Medical Center Groningen), I.E. Katsoulis, Anum Arif, Dalibor Antolovic, Maxim S. Petrov(University of Auckland), Daan W. Hommes(Leiden University Medical Center), Markus W. Büchler(Heidelberg University), Dong Yi Kim(Chonnam National University Hospital), Arash Choudhry, Mikhail V. Kukosh, Katsuhiko Yanaga(Sanno Medical Center), Mohamed Esmat, Sebastiaan W. Polle, G.R. Sagor, Henriëtte M. E. Quarles van Ufford, Willem A. Bemelman(Vrije Universiteit Amsterdam), Carlo Chiarla, Kazuhisa Yoshimoto, Casey D. Johnson, Dirk J. Gouma(Amsterdam UMC Location University of Amsterdam), Jörg Köninger, Marino Murazio, Shin Kon Kim(Chonnam National University Hospital), Gennaro Clemente, Yu Meng Tan, Arianeb Mehrabi, Christos Dervenis(Agia Olga Hospital), Carsten N. Gutt, Katsuya Hirai(Jikei University School of Medicine), Thomas M. van Gulik(Amsterdam University Medical Centers), P Basnyat, Simon R. Bramhall(Queen Elizabeth Hospital Birmingham), Gregor Vetter, J.I. Livingstone, Jan Wind, Abraham R. John, George Tzovaras, H. G. Gooszen, Sahib Singh
Cited by 0
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k